The current study aims to utilize the bacteria Paraclostridium benzoelyticum strain 5610 to synthesize bio‐genic silver nanoparticles (AgNPs). Biogenic AgNPs were thoroughly examined using various characterization techniques such as UV‐spectroscopy, XRD, FTIR, SEM, and EDX. Synthesis of AgNPs was confirmed by UV–vis analysis resulting in absorption peak at 448.31 nm wavelength. The SEM analysis indicated the morphological characteristics and size of AgNPs which was 25.29 nm. The face centered cubic (FCC) crystallographic structure was confirmed by XRD. Furthermore, FTIR study affirmed the capping of AgNPs by different compounds found in biomass of the Paraclostridium benzoelyticum strain 5610. Later, EDX was used to determine the elemental composition with respective concentration and distribution. Additionally, in the current study the antibacterial, anti‐inflammatory, antioxidant, anti‐aging, and anti‐cancer ability of AgNPs was assessed. The antibacterial activity of AgNPs was tested against four distinct sinusitis pathogens: Haemophilus in‐fluenza, Streptococcus pyogenes, Moraxella catarrhalis and Streptococcus pneumonia. AgNPs shows significant inhibition zone against Streptococcus pyogenes 16.64 ± 0.35 followed by 14.32 ± 071 for Moraxella catarrhalis. Similarly, the antioxidant potential was found maximum (68.37 ± 0.55%) at 400 μg/mL and decrease (5.48 ± 0.65%) at 25 μg/mL, hence the significant antioxidant ability was observed. Furthermore, anti‐inflammatory activity of AgNPs shows the strongest inhibitory action (42.68 ± 0.62%) for 15‐LOX with lowest inhibition activity for COX‐2 (13.16 ± 0.46%). AgNPs have been shown to exhibit significant inhibitory actions against the enzyme elastases AGEs (66.25 ± 0.49%), which are followed by AGEs of visperlysine (63.27 ± 0.69%). Furthermore, the AgNPs show high toxicity against HepG2 cell line which shows 53.543% reduction in the cell viability after 24 h of treatment. The anti‐inflammatory activity demonstrated a potent inhibitory effect of the bio‐inspired AgNPs. Overall, the biogenic AgNPs have the ability to be served for the treatments of anti‐aging and also due to their anti‐cancer, antioxidant abilities NPs may be a useful therapy choice for a variety of disorders including cancer, bacterial infections and other inflammatory diseases. Moreover, further studies are required in the future to evaluate their in vivo biomedical applications.
Highlights
Biogenic synthesis of AgNPs using Paraclostridium benzoelyticum Strain for the first time.
FTIR analysis confirmed capping of potent biomolecules which are of great use in applied field especially Nanomedicines.
Notable antimicrobial activity against sinusitis bacteria and cytotoxic potential of synthesized AgNPs on in vitro basis produce a new idea shifting us to treat cancerous cell lines.